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We present the case of a 27-year-old lady who was seen in the infertility clinic with a history of secondary infertility of a one-
year duration. She had a hysteroscopy and Mirena insertion for heavy periods. Coil strings were not found by the GP during
ﬁrst coil check six weeks after insertion. A pelvic ultrasound scan did not show any coil, and it was not investigated further with
a possible diagnosis of coil expulsion made. One year following that, she was seen in the infertility clinic. Initial investigations
revealed anovulation, and HSG located the coil to be extrauterine. Mirena was removed laparoscopically, and a month following
the removal she conceived. She is currently pregnant. This case highlights the eﬀect of extrauterine mirena coils on fertility by
possibly causing higher plasma levels of levonorgesterol and resulting suppression of ovulation. Laparoscopic removal of mirena
coil can help in restoration of fertility.
1.CaseReport
We present the case of a 27 year old lady who was seen in
the infertility clinic with a history of secondary infertility of
a one-year duration. Her BMI was 32. She had two children
born by vaginal delivery, and last childbirth was ﬁve years
ago. Following that she was investigated for heavy periods
andstress incontinenceandunderwent hysteroscopy,Mirena
insertion, TVT secure, and posterior repair on the same day.
During the ﬁrst coilcheck withher general practitioner(GP)
6 weeks after the insertion, the coil strings were not seen and
therefore an ultrasound scan was arranged. The Mirena coil
was not seen on the scan and was thought to be expelled. No
further investigation was arranged.
Approximately a year and a half following that she was
seen in the infertility clinic. She gave a history of few months
of implanon use for contraception before discontinuing and
trying for conception. She had irregular cycles varying from
4- to 8-week intervals and no history of intermenstrual
or postcoital bleeding. Her cervical smears were normal
and had a prior episode of CIN3 nine years ago treated
with LLETZ. There was a history of chlamydia and herpes
infections treated in the past. She had a medical problem
of ectopic heart beats due to inherited cardiac condition
of long QT syndrome for which she had an implantable
cardioverter-deﬁbrillator (ICD) inserted ﬁve years ago. This
was diagnosed following investigations of sudden cardiac
death of her brother. She was a nonsmoker and had 18 units
of alcohol per week. Her current partner was 34-years-old
and was ﬁt and well with no signiﬁcant past history. He had
fathered a child in his previous relationship.
Findings on clinical examination of the couple were nor-
mal. The initial investigations done revealed a normal follic-
ular phase, normal serum prolactin, and luteal phase serum
progesterone of 28.9 indicating anovulation or borderline
ovulation. The semen analysis was normal. A hysterosalpin-
gogram was arranged to check for the tubal patency and it
revealed both tubes to be patent and ﬁnding of misplaced
coil outside the uterus in the abdominal cavity.
The couple were reviewed with the investigation results
and the lady was counselled regarding a laparoscopy and
retrieval of the extrauterine Mirena coil which she agreed
to. She was advised to switch oﬀ the tachycardia compo-
nent of the ICD prior to the operative procedure. During2 Case Reports in Obstetrics and Gynecology
laparoscopy the coil was seen in the pouch of Douglas and
no adhesions were noted. The uterus was of normal size and
there was evidence of old fundal perforation. Both tubes and
ovaries were normal in appearance.
A followup was arranged in the infertility clinic three
months later. Prior to that she conﬁrmed having a positive
pregnancy one month after the Mirena coil removal.
She was referred to the high-risk pregnancy clinic for fol-
lowup in view of having a cardiac deﬁbrillator and previous
history of TVT. Her pregnancy is progressing uneventfully
and she is currently 25 weeks pregnant.
2.Reviewof theLiterature
Intrauterine contraception is a widely used, highly eﬀective
method of birth control. Mirena levonorgestrel intrauterine
system (LNG IUS) has been licensed in the UK as a contra-
ceptive since May 1995. It is a polymer cylinder mounted
on a T-shaped frame and covered with a release rate-
controlling membrane which releases 20 microgram/24h of
levonorgestrel. Most outstanding features of LNG IUS are its
highcontraceptiveeﬃcacyandreductionofmenstrual blood
ﬂow. It is approved for 5-year use. No single mode of action
can account for its contraceptive eﬃcacy. The endometrium
becomes thin and inactive, and the cervical mucus turns
scanty and viscous. Although ovulation may be disturbed
to some degree, estradiol production continues normally.
After removal of the IUS, normal fertility is regained after
a few months, with a near-normal 80% of women able to
conceivewithin12months.Sameisdemonstratedinourcase
report where the lady achieved conception two months after
removal of the Mirena coil.
Misplaced IUS may be asymptomatic, but more com-
monly,patientscomplainofirregularbleeding,pelvicpainor
cramping, dyspareunia, vaginal discharge, or absent strings.
If strings are not visible, the possible explanations could
be that IUS is intrauterine with strings broken or coiled in
cervix, expulsion which is unnoticed, or uterine perforation
and extrauterine migration.
Intrauterine contraceptive device (IUCD) expulsion is
a rare event occurring more often in the ﬁrst year of use
in approximately 6% using the LNG IUS or Mirena [1].
A retrospective cohort study [2] compared the dislocation
rate of the Multiload 375 IUD (ML 375) and the LNG IUS
in 214 women (107 subjects with each IUCD) and found
signiﬁcantly lower number of dislocations in LNG IUS users.
Previous expulsion was associated with a signiﬁcantly higher
risk for a reexpulsion in both IUCD groups. There is little
evidenceconcerningriskfactorsfortheexpulsionoftheLNG
IUS. The expulsion rate for the LNG IUS has been reported
to be slightly increased in women younger than 25 years
[3].
An ultrasound should be requested to detect a misplaced
IUS and conﬁrm its correct location within the uterus.
Accurate ultrasound detection of an IUCD and its position
depends on a variety of factors. These include such things as
the type of IUCD (copper, hormonal, or inert), the presence
of uterine anomalies or scarring, a retroverted uterus, and
other patient characteristics that may interfere with image
quality [4]. In addition, ultrasound is always operator de-
pendent, and interpretations may vary with the clinical
experience ofthe sonographer. Sonography is also important
in assessing the complications of IUCDs, including a low
position,associated infection, myometrial migration,uterine
perforation, and associated intrauterine or extrauterine pre-
gnancy. If an IUCDisknown to be present butnot visualized
sonographically, plain radiography is helpful in assessing the
location. A case report [5] concluded that judicious use of
a b d o m i n a lX - r a yc a nl e a dt oe a r l yd e t e c t i o no fm i g r a t e dI U S
and expedite removal. Rarely, hysteroscopy and laparoscopy
is necessary for localization.
A potentially serious complication is the perforation of
the uterus, with reported incidence of 0.5–1/1000 insertions
[6]. A study performed in The Netherlands [7] focused on
uterine perforations with an LNG IUS and reports an esti-
matedincidenceofatleast2.6per1000insertions. Thisstudy
concluded that perforations are signiﬁcantly underreported
and actual perforation rates are likely higher [7]. The risk of
perforation may be increased in lactating women, in women
with ﬁxed retroverted uteri, and during the postpartum
period. To decrease the risk of perforation postpartum, Mi-
rena insertion should be delayed a minimum of 6 weeks after
delivery or until uterine involution is complete [8].
After perforation, devices have been found in various
locations in the pelvis and abdomen. Extrauterine migration
of an intrauterine device can be life threatening and require
emergent surgical intervention and treatment [9]. Delayed
detection of perforation may result in migration outside the
uterine cavity, adhesions, peritonitis, intestinal perforations,
intestinal obstruction, abscesses, and erosion of adjacent
viscera. The potential migration of an IUCD and resultant
uterine perforation must be considered in the diﬀerential
diagnosis ofany womanusingthistypeofcontraceptionwho
presents with abdominal pain. More often, they may have a
more subtle presentation and have only mild tenderness on
examination. Therefore, it is important for the physician to
obtain a full history and physical examination and to include
these complications on their list of potential diagnoses [8]. It
has not been proven that the removal of an asymptomatic
displaced IUCD (neither medicated nor nonmedicated) is
indicated. Currently, it appears reasonable not to intervene
surgically in asymptomatic patients with an intra-abdominal
IUD after perforation [10]. This ﬁnding is contrary to the
recommendation of the Faculty of Sexual and Reproductive
Health which advises surgical retrieval of an extrauterine
device [10]. It suggests that the symptoms, age, and medical
history of the patient must be taken into account, as the
beneﬁts of surgery should be balanced against the risks. If
thewoman is asymptomatic theintra-abdominal IUDcanbe
removed by laparoscopy, in keeping with current guidelines.
However, if a laparotomy would be required, consideration
should be given to the morbidity and mortality this would
cause [11]. Based on our report, we suggest that extrauter-
ine IUS can be a factor implicated in women’s abnormal
bleeding and may interfere with ovulation. In infertility
cases, it would seem very reasonable to perform laparoscopic
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A recent study done at Netherlands Pharmacovigilance
Centre [12] reported that 8.5% of uterine perforations are
detected at the time of insertion. The study concluded that
uterine perforations can be asymptomatic and may remain
undetected for a long time after IUD insertion. Abdominal
pain, control/check-upvisits, orchangesinbleedingpatterns
are triggers for detection of perforation and should therefore
be taken seriously.
Extrauterine IUD including Mirena and copper coils
have the potential to cause adhesions. A study [13]ev a l u a t e d
eight cases of dislocated IUDs and at laparoscopy all
disclosed mild local peritoneal adhesions between omentum
and pelvic organs. The peritoneal adhesions potential of
LNG-IUS was found to be low, similar to that of the copper-
bearing IUD and there was no diﬀerence in the appearance
of the peritoneum in the presence of either a copper IUD or
a LNG-IUS. From the authors experience, adhesions is not a
common ﬁnding.
A previous case report [14]s h o w e dﬁ n d i n go fa ne x t r a -
uterine IUCD in a women who was being investigated for
secondary infertility and in whom there was a history of
missing/expulsion of Mirena. This suggests the association
of reduced fertility with extrauterine coils, similar to our
report.
Another case report published in 2003 [15]a n dw h i c h
is relevant to our case study reported that intraperitoneal
dislocated LNG-IUS resulted in plasma LNG levels 10-times
higher (4.7nmol/l) than the plasma level of LNG observed
with LNG-IUS placed in utero. They measured the LNG
and sex hormone-binding globulin plasma concentrations
prior to and following the laparoscopic removal. They found
that after removal of the device plasma levels drop by
15% to 4mol/l. The level of levonorgestrel does not have
any untoward eﬀects; however, it may continue to suppress
ovulation. Conclusion was that the higher levels suppress
ovulation, and, therefore, a misplaced LNG-IUS should be
removed when pregnancy is desired. Amenorrhoea reported
in another case study was also suggestive of this [16].
None of the studies comment on the long-term eﬀects of
leaving the device in situ as most are removed laparoscopi-
cally [17].
3.Conclusion
The levonorgestrel-releasing intrauterine system is a reliable,
reversible, low-maintenance method of long-term contra-
ception. Rates of failure are similar to those of female ster-
ilization, and the risk of expulsion is minimal for most users.
Ararebutpotentiallyseriouscomplicationisthatofuter-
ine perforation. This may occur either during the device’s
insertion or from its later embedment into the uterine wall
and subsequent migration through to the intra-abdominal
cavity. Perforation can cause internal scarring, infection, or
damage to other organs, and may require surgery.
Intraperitoneal dislocated Mirena can cause higher plas-
malevelsoflevonorgesterolcausingsuppressionofovulation
and resulting infertility. Removal of Mirena coil as shown in
our case report can help in restoration of fertility.
With regards to the limitation of our case report, we
did not measure the levonorgestrel level in blood to assess
its causal relationship with anovulation. However, achieving
conception within 2 months of removal of the Mirena coil
supports this association.
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